Found 1012 matching trials
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors PHASE2 Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration N/A In this study, investigators utilize a radiopathomics integrated Artificial...
Show More Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients PHASE1 This first-in-human open-label, multi center, dose-escalation and expansion...
Show More Location
Liverpool Hospital
Learn More & Join Trial
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer PHASE3 This is a randomized, prospective, multicenter, open-label, Phase III clini...
Show More Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Learn More & Join Trial
Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) PHASE2 The purpose of this study is to evaluate the safety and efficacy of pembrol...
Show More Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial